Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2021
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid LeukemiaPierre-Yves Dumas, Arnaud Villacreces, Amélie V Guitart, et al.
BMC Cancer|November 14, 2018
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasmsPierre-Yves Dumas, Olivier Mansier, Valerie Prouzet-Mauleon, et al.
European Journal of Haematology|May 8, 2015
Molecular diagnostics of myeloproliferative neoplasmsStephen E Langabeer, Hajnalka Andrikovics, Julia Asp, et al.
Cancers|December 8, 2019
The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated DegradationOlivier Mansier, Valérie Prouzet-Mauléon, Gwénaële Jégou, et al.
Genes, Chromosomes & Cancer|November 22, 2022
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significanceVictor-Emmanuel Brett, Nicolas Lechevalier, Franck Trimoreau, et al.
Haematologica|March 30, 2019
Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXLPierre-Yves Dumas, Cécile Naudin, Séverine Martin-Lannerée, et al.
Nature Communications|November 4, 2022
JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysmRida Al-Rifai, Marie Vandestienne, Jean-Rémi Lavillegrand, et al.
Leukemia|June 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Eric Lippert, Lina Benajiba, et al.
Pageof 3